Table 145Ciclosporin versus best supportive care – economic summary of findings

StudyIncremental costIncremental effectsICERUncertainty
Sizto 2009− £1987 (a)0.079 QALYs (b)DominatesCosts 95% CI: −3313 to −597
QALYs 95% CI: 0.044 to 0.116
Visual inspection of 95% confidence interval ellipses indicates that ciclosporin dominates best supportive care in 100% of simulations
Woolacott 2006− £452 (c)0.122 QALYsDominatesCost 95% CI: −795 to 41
QALYs 95% CI: 0.072 to 0.175
Probability of being more cost-effective than best supportive care could not be determined from the study report.
a

2005/06 UK Pounds; does not include costs of outpatient of GP visits

b

Time horizon not reported

c

2004/05 UK Pounds

From: 10, Systemic non-biological therapy

Cover of Psoriasis
Psoriasis: Assessment and Management of Psoriasis.
NICE Clinical Guidelines, No. 153.
National Clinical Guideline Centre (UK).
Copyright © National Clinical Guideline Centre - October 2012.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.